Cardiovascular effects of marine omega-3 fatty acids

被引:411
作者
Saravanan, Palaniappan [1 ,2 ]
Davidson, Neil C. [2 ]
Schmidt, Erik B. [3 ]
Calder, Philip C. [4 ]
机构
[1] Univ Manchester, Cardiovasc Res Grp, Core Technol Facil, Manchester Acad Hlth Sci Ctr, Manchester M13 9NT, Lancs, England
[2] Univ Hosp S Manchester NHS Fdn Trust, Manchester, Lancs, England
[3] Aarhus Univ Hosp, Aalborg Hosp, Cardiovasc Res Ctr, Dept Cardiol, Aalborg, Denmark
[4] Univ Southampton, Sch Med, Inst Human Nutr, Southampton, Hants, England
关键词
POLYUNSATURATED-FATTY-ACIDS; CORONARY-HEART-DISEASE; FISH-OIL SUPPLEMENTATION; ARTERY-BYPASS SURGERY; RAT VENTRICULAR MYOCYTES; ATRIAL-FIBRILLATION; EICOSAPENTAENOIC ACID; MYOCARDIAL-INFARCTION; DOCOSAHEXAENOIC ACID; DIETARY FISH;
D O I
10.1016/S0140-6736(10)60445-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Much evidence shows that the marine omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid have beneficial effects in various cardiac disorders, and their use is recommended in guidelines for management of patients after myocardial infarction. However, questions have been raised about their usefulness alongside optimum medical therapies with agents proven to reduce risk of cardiac events in high-risk patients. Additionally, there is some evidence for a possible pro-arrhythmic effect in subsets of cardiac patients. Some uncertainly exists about the optimum dose needed to obtain beneficial effects and the relative merit of dietary intake of omega-3 polyunsaturated fatty acids versus supplements. We review evidence for the effects of omega-3 polyunsaturated fatty acids on various cardiac disorders and the risk factors for cardiac disease. We also assess areas of uncertainty needing further research.
引用
收藏
页码:540 / 550
页数:11
相关论文
共 106 条
[31]   LONG-TERM EFFECTS OF N-3 POLYUNSATURATED FATTY-ACIDS ON HEMOSTATIC VARIABLES AND BLEEDING EPISODES IN PATIENTS WITH CORONARY-ARTERY DISEASE [J].
ERITSLAND, J ;
ARNESEN, H ;
SELJEFLOT, I ;
KIERULF, P .
BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (01) :17-22
[32]   Differential effects of docosahexaenoic acid on contractions and L-type Ca2+ current in adult cardiac myocytes [J].
Ferrier, GR ;
Redondo, I ;
Zhu, JQ ;
Murphy, MG .
CARDIOVASCULAR RESEARCH, 2002, 54 (03) :601-610
[33]  
Frost L, 2005, AM J CLIN NUTR, V81, P50
[34]   PREVENTING RESTENOSIS WITH FISH OILS FOLLOWING CORONARY ANGIOPLASTY - A METAANALYSIS [J].
GAPINSKI, JP ;
VANRUISWYK, JV ;
HEUDEBERT, GR ;
SCHECTMAN, GS .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (13) :1595-1601
[35]   Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials [J].
Geleijnse, JM ;
Giltay, EJ ;
Grobbee, DE ;
Donders, ART ;
Kok, FJ .
JOURNAL OF HYPERTENSION, 2002, 20 (08) :1493-1499
[36]   Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention) [J].
Gerstein, Hertzei C. .
AMERICAN HEART JOURNAL, 2008, 155 (01) :26-32
[37]   Omega-3 fatty acids in adipose tissue and risk of myocardial infarction -: The EURAMIC study [J].
Guallar, E ;
Aro, A ;
Jiménez, FJ ;
Martín-Moreno, JM ;
Salminen, I ;
van't Veer, P ;
Kardinaal, AFM ;
Gómez-Aracena, J ;
Martin, BC ;
Kohlmeier, L ;
Kark, JD ;
Mazaev, VP ;
Ringstad, J ;
Guillén, J ;
Riemersma, RA ;
Huttunen, JK ;
Thamm, M ;
Kok, FJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (04) :1111-1118
[38]   Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives [J].
Harris, William S. ;
Miller, Michael ;
Tighe, Ann P. ;
Davidson, Michael H. ;
Schaefer, Ernst J. .
ATHEROSCLEROSIS, 2008, 197 (01) :12-24
[39]   The Omega-3 Index: a new risk factor for death from coronary heart disease? [J].
Harris, WS ;
von Schacky, C .
PREVENTIVE MEDICINE, 2004, 39 (01) :212-220
[40]   Fish oil supplementation: Evidence for health benefits [J].
Harris, WS .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2004, 71 (03) :208-+